Dyne Medical Group Selected for the 2026 Global Small Giants 1000+ Project
Recognized for global export competitiveness; accelerating global market expansion based on overseas networks and training infrastructure
[Medical Times / Daily Bosa = Reporter In-gyu Oh] Dyne Medical Group, a Korean company specializing in urological medical devices, announced on June 24 that it has been selected for the โ2026 Global Small Giants 1000+ Projectโ organized by the Ministry of SMEs and Startups.
Certificate of Designation for the Global Small Giants 1000+ Project
Photo courtesy of Dyne Medical Group
The Global Small Giants 1000+ Project is a government support program designed to identify small and medium-sized enterprises with strong growth potential and export capabilities, and to foster them as globally competitive specialized companies. Selected companies are eligible for various forms of support tailored to their stage of growth, including export vouchers, preferential financial, guarantee and insurance programs, overseas marketing support, and R&D-linked assistance.
Dyne Medical Group is a specialized medical device company that develops and manufactures urological devices, including its single-use flexible ureteroscope, URUS. The company has continued to expand its export competitiveness through ongoing investment in global market entry and the development of overseas networks.
Dyne Medical Group is currently expanding its overseas sales mainly in Indonesia and Uzbekistan, strengthening its presence in the global market.
The company is also pursuing entry into key markets such as Japan, Taiwan, Singapore, and the United States. By establishing cooperative systems with country-specific distribution partners and securing local regulatory approvals, Dyne Medical Group is reinforcing the foundation for its global business. Based on market expansion in major countries, the company plans to further accelerate the growth of its global business.
Alongside this overseas business expansion, Dyne Medical Group has also been steadily increasing its contact points with global medical professionals. The company continues to participate in major international academic conferences and exhibitions, including the American Urological Association (AUA) and the World Congress of Endourology and Uro-Technology (WCET), where it introduces its products, explores new markets, and builds global partnerships.
Dyne Medical Group is also actively working to establish overseas training infrastructure. The company has selected Uzbekistan and Indonesia as strategic hub markets and operates training centers for local medical professionals, supporting product education and the expansion of clinical techniques. Through these efforts, the company is building a long-term customer base and a sustainable export structure.
In terms of product competitiveness, Dyne Medical Group is further strengthening its foundation for global market entry. The company is pursuing overseas market expansion centered on URUS, its FDA 510(k)-cleared single-use flexible ureteroscope, and Port-C, an endoscopic procedure accessory, while enhancing its global competitiveness through innovative product development.
โThis selection for the Global Small Giants 1000+ Project is a meaningful achievement that recognizes not only Dyne Medical Groupโs technological capabilities, but also its growth potential and export competitiveness in the global market,โ said Sung-hoon Lee, CEO of Dyne Medical Group. โWe will continue to grow into a competitive medical device company in the global market by expanding our international academic network, building training infrastructure, and strengthening global partnerships.โ
He added, โWe will actively utilize the governmentโs various support programs to accelerate our entry into new countries and expand our global distribution network, while striving to establish ourselves as a representative Korean company in the field of urological medical devices.โ
Dyne Medical Group Selected for the 2026 Global Small Giants 1000+ Project
Recognized for global export competitiveness; accelerating global market expansion based on overseas networks and training infrastructure
[Medical Times / Daily Bosa = Reporter In-gyu Oh] Dyne Medical Group, a Korean company specializing in urological medical devices, announced on June 24 that it has been selected for the โ2026 Global Small Giants 1000+ Projectโ organized by the Ministry of SMEs and Startups.
Certificate of Designation for the Global Small Giants 1000+ Project
Photo courtesy of Dyne Medical Group
The Global Small Giants 1000+ Project is a government support program designed to identify small and medium-sized enterprises with strong growth potential and export capabilities, and to foster them as globally competitive specialized companies. Selected companies are eligible for various forms of support tailored to their stage of growth, including export vouchers, preferential financial, guarantee and insurance programs, overseas marketing support, and R&D-linked assistance.
Dyne Medical Group is a specialized medical device company that develops and manufactures urological devices, including its single-use flexible ureteroscope, URUS. The company has continued to expand its export competitiveness through ongoing investment in global market entry and the development of overseas networks.
Dyne Medical Group is currently expanding its overseas sales mainly in Indonesia and Uzbekistan, strengthening its presence in the global market.
The company is also pursuing entry into key markets such as Japan, Taiwan, Singapore, and the United States. By establishing cooperative systems with country-specific distribution partners and securing local regulatory approvals, Dyne Medical Group is reinforcing the foundation for its global business. Based on market expansion in major countries, the company plans to further accelerate the growth of its global business.
Alongside this overseas business expansion, Dyne Medical Group has also been steadily increasing its contact points with global medical professionals. The company continues to participate in major international academic conferences and exhibitions, including the American Urological Association (AUA) and the World Congress of Endourology and Uro-Technology (WCET), where it introduces its products, explores new markets, and builds global partnerships.
Dyne Medical Group is also actively working to establish overseas training infrastructure. The company has selected Uzbekistan and Indonesia as strategic hub markets and operates training centers for local medical professionals, supporting product education and the expansion of clinical techniques. Through these efforts, the company is building a long-term customer base and a sustainable export structure.
In terms of product competitiveness, Dyne Medical Group is further strengthening its foundation for global market entry. The company is pursuing overseas market expansion centered on URUS, its FDA 510(k)-cleared single-use flexible ureteroscope, and Port-C, an endoscopic procedure accessory, while enhancing its global competitiveness through innovative product development.
โThis selection for the Global Small Giants 1000+ Project is a meaningful achievement that recognizes not only Dyne Medical Groupโs technological capabilities, but also its growth potential and export competitiveness in the global market,โ said Sung-hoon Lee, CEO of Dyne Medical Group. โWe will continue to grow into a competitive medical device company in the global market by expanding our international academic network, building training infrastructure, and strengthening global partnerships.โ
He added, โWe will actively utilize the governmentโs various support programs to accelerate our entry into new countries and expand our global distribution network, while striving to establish ourselves as a representative Korean company in the field of urological medical devices.โ